ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 3 of 24 for:    "secondhand smoke" | Recruiting, Not yet recruiting, Available Studies

An Intervention to Reduce Second Hand Smoke Exposure Among Pediatric Emergency Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02531594
Recruitment Status : Recruiting
First Posted : August 24, 2015
Last Update Posted : March 21, 2018
Sponsor:
Collaborator:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Information provided by (Responsible Party):
Children's Hospital Medical Center, Cincinnati

Brief Summary:
This study will test the efficacy of a cessation intervention for caregivers in a large, inner-city Pediatric Emergency Department. The investigators will randomize 750 caregivers who smoke who present to our Pediatric Emergency Department with their child who has a Second Hand Smoke exposure-related illness to either one of two conditions: 1) Screening, Brief Intervention, and Assisted Referral to Treatment (SBIRT); or 2) Healthy Habits Control (HHC). The Screening, Brief Intervention, and Assisted Referral to Treatment condition will include a brief form of the Clinical Practice Guideline: Treating Tobacco Use and Dependence, motivational interviewing, engaging and personalized materials on the effects of smoking and Second Hand Smoke exposure, immediate access to caregivers' choice of cessation resources (e.g., Quitline, smokefree.gov, or txt2quit), a 12-week supply of nicotine replacement therapy and weekly booster materials for 12 weeks. The Healthy Habits Control program will be used as an attention control in which caregivers will receive instruction on healthy lifestyle choices to improve the child's health.

Condition or disease Intervention/treatment Phase
Smoking Cessation Behavioral: SBIRT Behavioral: HHC Not Applicable

Detailed Description:
This study will test the efficacy of a cessation intervention for caregivers in a large, inner-city Pediatric Emergency Department. The proposed Screening, Brief Intervention, and Assisted Referral to Treatment will highlight the effects of Second Hand Smoke exposure on the child's health. the investigators will randomize 750 caregivers who smoke who present to our Pediatric Emergency Department with their child who has a Second Hand Smoke exposure related illness to either one of two conditions: 1) Screening, Brief Intervention, and Assisted Referral to Treatment; or 2) Healthy Habits Control. The Screening, Brief Intervention, and Assisted Referral to Treatment condition will use components shown to be effective in the out-patient setting but not yet tested in the Pediatric Emergency Department setting. It will include a brief form of the Clinical Practice Guideline: Treating Tobacco Use and Dependence, motivational interviewing, engaging and personalized materials on the effects of smoking and Second Hand Smoke exposure, immediate access to caregivers' choice of cessation resources (e.g., Quitline, smokefree.gov, or txt2quit), a 12-week supply of nicotine replacement therapy and weekly booster materials for 12 weeks. The Healthy Habits Control program has been previously developed and used in the out-patient setting, and will be used as an attention control in which caregivers will receive instruction on healthy lifestyle choices to improve their child's health. Cessation assistance will be offered at the study's conclusion. If effective, the Screening, Brief Intervention, and Assisted Referral to Treatment model could be routinely used in the Pediatric Emergency Department setting, which could reach at least one million smokers a year, and could result in significant reductions in caregivers' tobacco use, Second Hand Smoke exposure related pediatric illness, and costs in this population. In addition, the investigators' results will inform the conduct of public health research efforts aimed at adults via the Pediatric Emergency Department.

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 750 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: An Intervention to Reduce Second Hand Smoke Exposure Among Pediatric Emergency Patients
Actual Study Start Date : April 6, 2016
Estimated Primary Completion Date : May 2020
Estimated Study Completion Date : June 2020

Arm Intervention/treatment
Experimental: SBIRT

An assessment form, motivational interviewing, personalized educational materials, immediate access to cessation resources, a 12-week supply of nicotine replacement therapy and weekly booster materials for 12 weeks.

nicotine

Behavioral: SBIRT
The Social Worker will provide caregivers with the brief (10-15 minute) "Advise, Assess, Assist" intervention based on the Clinical Practice Guidelines, and tailored on levels of motivation to quit and tobacco dependence. Patients in this group will receive Nicotine Replacement Therapy vouchers, immediate connection to cessation resources, and intervention materials.

Placebo Comparator: HHC
The Healthy Habits Control program has been previously developed and used in the out-patient setting, and will be used as an attention control in which caregivers will receive instruction on healthy lifestyle choices to improve their child's health. Cessation assistance will be offered at the study's conclusion.
Behavioral: HHC
The Social Worker will provide caregivers with the brief (10-15 minute) "Lets Go! 5-2-1-0" intervention which is a child obesity prevention program. Patients in this group will receive motivational interviewing in regards to helping children and families eat healthy and be active. This group will receive water bottle vouchers, immediate connection to 5-2-1-0 resources, and intervention materials.




Primary Outcome Measures :
  1. self-reported prolonged abstinence at 6 weeks [ Time Frame: 6 weeks post enrollment ]
    Primary outcomes are self-reported prolonged abstinence at 6-weeks post-enrollment, validated in all participants via salivary cotinine levels.

  2. self-reported prolonged abstinence at 6 months [ Time Frame: 6months post enrollment ]
    Primary outcomes are self-reported prolonged abstinence at 6 months post-enrollment, validated in all participants via salivary cotinine levels.


Secondary Outcome Measures :
  1. number of cigarettes smoked at 6 weeks [ Time Frame: 6 weeks post enrollment ]
    Secondary outcomes include number of cigarettes smoked at 6 weeks post enrollment.

  2. number of cigarettes smoked at 6 months [ Time Frame: 6 months post enrollment ]
    Secondary outcomes include number of cigarettes smoked at 6 months post enrollment.

  3. Number of quit attempts at 6 weeks [ Time Frame: 6 weeks post enrollment ]
    Secondary outcomes include number of quit attempts at 6 weeks post enrollment.

  4. Number of quit attempts at 6 months [ Time Frame: 6 months post enrollment ]
    Secondary outcomes include number of quit attempts at 6 months post enrollment.

  5. Readiness to quit at 6 weeks [ Time Frame: 6 weeks post enrollment ]
    Secondary outcomes include readiness to quit at 6 weeks post enrollment as measured by a readiness to quit scale.

  6. Readiness to quit at 6 months [ Time Frame: 6 months post enrollment ]
    Secondary outcomes include readiness to quit at 6 months post enrollment as measured by a readiness to quit scale.

  7. Use of cessation resources at 6 weeks [ Time Frame: 6 weeks post enrollment ]
    Secondary outcomes include use of cessation resources at 6 weeks post enrollment.

  8. Use of cessation resources at 6 months [ Time Frame: 6 months post enrollment ]
    Secondary outcomes include use of cessation resources at 6 months post enrollment.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:Eligible participants must:

  1. be > age 18;
  2. be accompanying a child 0-17 years of age who is presenting to the Pediatric Emergency Department with:

    • a stable condition, that is, patients who are not critically ill and do not require immediate treatment and intervention by the Pediatric Emergency Department practitioner and
    • a potentially Second Hand Smoke exposure related chief complaint (such as wheezing, difficulty breathing, cough) as outlined by the U.S. Surgeon General;45
  3. be a daily smoker;
  4. have currently or recently smoked inside their home;
  5. speak and read English, and
  6. have a permanent address and a working cell or landline number.
  7. Live within a 50 mile radius.
  8. Child is a non-smoker.

Exclusion Criteria: Caregivers will be excluded if

  1. their child has a tracheostomy or
  2. if the caregivers are tobacco chewers only,
  3. if the caregivers are using pharmacologic cessation treatment,
  4. or plan to move within the study period.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02531594


Contacts
Contact: Lara Stone, MA (513)-636-3526 lara.stone@cchmc.org

Locations
United States, Ohio
Cincinnati Children's Hospital Medical Center Recruiting
Cincinnati, Ohio, United States, 45229
Contact: Lara Stone, MA    513-636-3526    lara.stone@cchmc.org   
Principal Investigator: E Melinda Mahabee-Gittens, M.D., MS         
Sponsors and Collaborators
Children's Hospital Medical Center, Cincinnati
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Investigators
Principal Investigator: E. Melinda Mahabee-Gittens, MD Children's Hospital Medical Center, Cincinnati